InsiderClue
Insiders · Profile

Kalif Eliyahu Sharon

EVP, Chief Financial Officer at TEVA PHARMACEUTICAL INDUSTRIES. Filing since 22 Aug 2022. CIK 0001798443

Company
Date
Role
Action
Shares
Amount
Of holding
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
11 Jun 2026
EVP, Chief Financial Officer
Sold on a plan
106,563
$3.63M
61.9%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
14 May 2026
EVP, Chief Financial Officer
Sold on a plan
153,251
$5.46M
47.1%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
26 Feb 2026
EVP, Chief Financial Officer
Sold on a plan
345,810
$11.63M
85.7%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
12 Jun 2025
EVP, Chief Financial Officer
Sold on a plan
55,775
$952.46K
12.1%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
28 Feb 2025
EVP, Chief Financial Officer
Sold on a plan
55,750
$903.46K
27.4%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
6 Mar 2024
EVP, Chief Financial Officer
Sold on a plan
77,550
$1.05M
27.6%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
7 Aug 2023
EVP, Chief Financial Officer
Sold at will
35,125
$341.89K
26.2%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
22 Aug 2022
EVP, Chief Financial Officer
Sold, plan not stated
55,500
$558.70K
85.5%
8 decisions on file.